/주식/NRXP
NRXP

NRXP

USD

NRX Pharmaceuticals Inc. Common Stock

$2.450-0.220 (-8.240%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$2.670

고가

$2.700

저가

$2.440

거래량

0.08M

기업 기본 정보

시가총액

58.2M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.49M

거래소

NCM

통화

USD

52주 범위

저가 $1.12현재가 $2.450고가 $6.01

관련 뉴스

Analyst Upgrades

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals with a Buy and maintains $34 price target.

더 보기
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target
GlobeNewswire

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

ONE-D is the first reported protocol to achieve remission from treatment-resistant depression with a single day of treatment, using an FDA-cleared device.HOPE is one of the first Ampa deployments nationwide and is now

더 보기
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
Analyst Upgrades

Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $47

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals with a Buy and raises the price target from $46 to $47.

더 보기
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $47
Analyst Upgrades

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals with a Buy and maintains $34 price target.

더 보기
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target